Nongonierma AB, Paolella S, Mudgil P, Maqsood S, FitzGerald RJ
1 Theres no dedicated cardiovascular outcomes trial for retatrutide yet
It is one part of a bigger picture, part of our full medical weight loss program
Algunos efectos secundarios comunes incluyen: Nuseas Vmitos Congestin nasal Diarrea Inquietud Insomnio Olor corporal (olor a pescado) Algunos efectos secundarios graves pueden incluir: Taquicardia (frecuencia cardaca rpida) Hipertensin (presin arterial alta) Fiebre Almacenamiento Almacenar a temperatura ambiente controlada
Clinical trials have shown reductions in liver fat and improvements in fibrosis markers over the course of treatment
Effect of CagriSema on cardiovascular risk factors and leptin There were no differences between the groups of patients randomized to CagriSema, cagrilintide, and semaglutide in terms of plasma lipid parameters [10]